MINT-LEVOCARB (2017-12-13)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| All lots | B. MINT-LEVOCARB 25/100mg (Carbidopa 25mg, Levodopa 100mg) | - Recalling Firm
- Mint Pharmaceuticals Inc.
- 1093 Meyerside Drive, Unit #1
- Mississauga
- L5T 1J6
- Ontario
- CANADA
- Marketing Authorization Holder
- Mint Pharmaceuticals Inc.
- 1093 Meyerside Drive, Unit #1
- Mississauga
- L5T 1J6
- Ontario
- CANADA
| Tablet | DIN 02457962 | Carbidopa 25mg, Levodopa 100mg |
| All lots | C. MINT-LEVOCARB 25/250mg (Carbidopa 25mg, Levodopa 250mg) | - Recalling Firm
- Mint Pharmaceuticals Inc.
- 1093 Meyerside Drive, Unit #1
- Mississauga
- L5T 1J6
- Ontario
- CANADA
- Marketing Authorization Holder
- Mint Pharmaceuticals Inc.
- 1093 Meyerside Drive, Unit #1
- Mississauga
- L5T 1J6
- Ontario
- CANADA
| Tablet | DIN 02457970 | Carbidopa 25mg, Levodopa 250mg |
| All Lots | A. MINT-LEVOCARB 10/100mg (Carbidopa 10mg, Levopdoba 100mg) | - Recalling Firm
- Mint Pharmaceuticals Inc.
- 1093 Meyerside Drive, Unit #1
- Mississauga
- L5T 1J6
- Ontario
- CANADA
- Marketing Authorization Holder
- Mint Pharmaceuticals Inc.
- 1093 Meyerside Drive, Unit #1
- Mississauga
- L5T 1J6
- Ontario
- CANADA
| Tablet | DIN 02457954 | Carbidopa 10mg, Levodopa 100mg |
Affected Products
-
MINT-LEVOCARB 10/100mg (Carbidopa 10mg, Levopdoba 100mg)
-
MINT-LEVOCARB 25/100mg (Carbidopa 25mg, Levodopa 100mg)
-
MINT-LEVOCARB 25/250mg (Carbidopa 25mg, Levodopa 250mg)
Potential product quality concerns as a result of deficiencies in Good Manufacturing Practices (GMP) at the finished product manufacturer.